| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.4M | +18.8% |
| Cost of Revenue | $35.8M | +9.4% |
| Gross Profit | $73.6M | +23.9% |
| R&D Expense | $0 | — |
| Operating Income | $11.7M | +185.3% |
| Pre-tax Income | $7.0M | +135.9% |
| Income Tax | $1.8M | +150.8% |
| Net Income | $5.1M | +125.5% |
| EPS (Basic) | $0.28 | +125.5% |
| EPS (Diluted) | $0.27 | +124.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.4M | +74.6% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $37.8M | -1.2% |
| Current Assets | $64.7M | +19.9% |
| Total Assets | $176.9M | +3.4% |
| Current Liabilities | $21.3M | +14.0% |
| Long-term Debt | $26.3M | -23.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.7M | +282.8% |
| Capital Expenditures | $58K | -48.2% |
| Investing Cash Flow | $68K | +115.1% |
| Financing Cash Flow | -$8.8M | -79.1% |
| Free Cash Flow | $18.7M | +290.6% |
| $48.6M |
| -10.2% |
| Stockholders' Equity | $128.3M | +9.7% |